Recorded fact · drug.label_indication

drug.label_indication for pomalidomide|multiple-myeloma

One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact bd367262 resolves to.

The record

Fact id	`bd36726295b1c715004eff55`
Entity	drug: pomalidomide\|multiple-myeloma
Field	drug.label_indication
Source	api.fda.gov
Read on	2026-11-10T19:02:47.536Z
Source version	openfda-label-20251118
Method	extract
Verification	verified
Licence	CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels
Edition	2026-11, Merkle root `006ab9a329709cbe...`

The verifying quote

in combination with dexamethasone, for patients with multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of t

Shown with dashes as hyphens. SHA-256 of the exact stored quote: 7c624d91c7b5724e0bda42291cd94d7060d03be8aaaa4eace40886ccaa34847a.

The value

{
 "ingredient": "POMALIDOMIDE",
 "conditionId": "multiple-myeloma",
 "conditionName": "Multiple Myeloma",
 "matchedAlias": "multiple myeloma",
 "context": "indication",
 "brand": "Pomalidomide",
 "identifiedVia": "generic_name",
 "extractor": 5,
 "labelSetId": "0169dbda-53df-4cd9-b989-ff7544f1bdf5",
 "labelEffectiveTime": "20251118",
 "labelsRead": 11,
 "labelsNaming": 11,
 "registryEditionRoot": "1b44e76f5da1a417",
 "meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}

SHA-256 of the exact stored value: e077cc280507c34b6e9447b8126e5aa3a42965e4977c88454a2fbe4ee5d4138b.

This fact as data (JSON) · Check an answer against its receipt · Licence

Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.